Onkologische Embolisation-Reference-Cited by-同舟云学术

Onkologische Embolisation

Published:2020-11-29 Issue: Volume: Page:409-504
ISSN:
Container-title:Angiofibel
language:
Short-container-title:

Author:

Huppert Peter,Kortes Nikolas,Kratochwil Clemens,Radeleff Boris,Schmitz Anne,Stampfl Ulrike

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/978-3-662-56243-7_14

Reference226 articles.

1. Abbott AM, Doepker MP, Kim Y, Perez MC, Gandle C, Thomas KL, Choi J, Shridhar R, Zager JS (2017) Hepatic progression-free and overall survival after regional therapy to the liver for metastatic melanoma. Am J Clin Oncol. [PMID: 28059929]. https://doi.org/10.1097/COC0000000000000356

2. Akinwande O, Scoggins C, Martin RCG (2016) Early experience with 70–150 μm irinotecan drug-eluting beads (M1-DEBIRI) fort he treatment of unresectable hepatic colorectal metastases. Anticancer Res 36:3413–3418

3. Albert M, Kiefer MV, Sun W et al (2011) Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol and polyvinyl alcohol. Cancer 117:343–352

4. Alexander HR Jr, Butler CC (2010) Development of isolated hepatic perfusion via the operative and percutaneous techniques for Patients with isolated and unresectable liver metastases. Cancer J 16(2):132–141. [PMID: 20404610]. https://doi.org/10.1097/PPO.0b013e3181db9c0a

5. Alexander HR Jr, Bartlett DL, Libutti SK, Pingpank JF, Fraker DL, Royal R, Steinberg SM, Helsabeck CB, Beresneva TH (2009) Analysis of factors associated with outcome in patients undergoing isolated hepatic perfusion for unresectable liver metastases from colorectal center. Ann Surg Oncol 16(7):1852–1859. [PMID: 19434456]. https://doi.org/10.1245/s10434-009-0482-9